<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) is associated with B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> such as Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and post-transplantation <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, which originate from clonal germinal center (GC) B cells </plain></SENT>
<SENT sid="1" pm="."><plain>During the process of somatic hypermutation, GC B cells can acquire deleterious or nonsense mutations in the heavy and light immunoglobulin genes </plain></SENT>
<SENT sid="2" pm="."><plain>Such mutations abrogate the cell surface expression of the B-cell receptor (BCR), which results in the elimination of these nonfunctional B cells by immediate <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>EBV encodes several latent genes, among them latent membrane protein 1 (LMP1) and LMP2A, which are regularly expressed in EBV-positive Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and posttransplantation <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Since LMP1 and LMP2A mimic the function of 2 key receptors on B cells, CD40 and BCR, respectively, we wanted to learn whether <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> can rescue proapoptotic GC B cells with crippling mutations in the heavy chain immunoglobulin locus from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>We show here that BCR-negative GC B cells readily enter the cell cycle upon <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with EBV in vitro and yield clonal lymphoblastoid cell lines that are incapable of expressing a functional BCR because the rearranged and formerly functional heavy chain immunoglobulin alleles carry deleterious mutations </plain></SENT>
<SENT sid="6" pm="."><plain>Our findings imply an important role for EBV in the process of <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> in certain cases of Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and posttransplantation <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>